Quantum BioPharma
QNTM | NASDAQ
$1.44
-$0.17 (-10.56%)
At close: Nov 16, 2026, 4:00 PM ET
$1.45
+$0.01 (+0.69%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-10.56%
(1D)No price chart data available for 1D timeframe.
Rating
29
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #837/1021 (Top 82%)
Key Statistics
Market Data
Market Cap $11.49M
1D Range
1.33 1.59
52W Range
1.33 11.41
Valuation (TTM)
PE -0.34
PB 0.97
EV/EBITDA 0.00
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -56.0%
SBC Adj. FCF Yield -70.8%
SBC Impact -26.4%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 42.0% |
40.6%
FCF 3Y | 5Y 3.4% |
36.6%
Returns
ROA -114.6%
ROE -291.6%
ROIC -6.9%
Financial Health
Net Cash
$11.49M
Current Ratio 1.72
Interest Coverage -1.40
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses ...
Sector Healthcare
Industry Biotechnology
Employees 17
IPO Date Jun 8, 2018
Website www.quantumbiopharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove QNTM